SCINAI IMMUNOTHERAPEUTICS
BiondVax Pharmaceuticals Ltd.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79387398 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Timeline
| 2023-08-22 | Application Filed |
| 2024-01-11 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2024-01-11 | Status: Live/Pending |
| 2024-01-12 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  BiondVax Pharmaceuticals Ltd. |
| Address | Jerusalem BioPark Building, 2nd Floor, Hadassah Ein Kerem Campus Jerusalem IL |
| Legal Entity Type | Corporation |
| Legal Entity State | IL |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Antigen-binding polypeptides for prevention and treatment of infectious diseases, immune and inflammatory diseases, malignancies and cancers, metabolic diseases, cardiovascular diseases, diseases of the central nervous system, neurogenerative diseases; immunoglobulin moieties, fragments or derivatives thereof for prevention and treatment of infectious diseases, immune and inflammatory diseases, malignancies and cancers, metabolic diseases, cardiovascular diseases, diseases of the central nervous system, neurogenerative diseases |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2024-01-11 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2024-01-12 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2024-01-16 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2024-04-23 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2024-04-23 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2024-04-24 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2024-05-01 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2024-05-01 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2024-05-22 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2024-07-08 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2024-07-08 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2024-07-08 | 12 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2024-07-09 | 13 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2024-07-09 | 14 GNSL F:First Action |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2024-07-09 | 15 GNS3 O:Outgoing Correspondence |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2024-07-18 | 16 ADCH M: |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2024-07-23 | 17 CNSA O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2024-07-23 | 18 ERSI I:Incoming Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 